S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Recession risks are fading, business economists say, but political tensions pose threat to economy
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000

RayzeBio (RYZB) News Today

$62.32
+0.05 (+0.08%)
(As of 02/9/2024 08:56 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media
SourceHeadline
marketbeat.com logoVivo Capital LLC Acquires Shares of 633,576 RayzeBio, Inc. (NASDAQ:RYZB)
marketbeat.com - February 6 at 1:39 PM
marketbeat.com logoVersant Venture Management LLC Acquires New Stake in RayzeBio, Inc. (NASDAQ:RYZB)
marketbeat.com - January 22 at 2:37 PM
marketbeat.com logoPlatinum Investment Management Ltd. Buys New Position in RayzeBio, Inc. (NASDAQ:RYZB)
marketbeat.com - January 21 at 9:42 AM
marketbeat.com logoIPO watch 2024: Which new stocks will hit the market? (RYZB)
marketbeat.com - January 8 at 7:03 AM
businesswire.com logoRAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB
businesswire.com - December 31 at 10:01 PM
businesswire.com logoRAYZEBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB
businesswire.com - December 31 at 8:07 PM
marketbeat.com logoBristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals (RYZB)
marketbeat.com - December 29 at 8:39 AM
marketbeat.com logoRayzeBio, Inc. (NASDAQ:RYZB) to Post FY2023 Earnings of ($3.25) Per Share, William Blair Forecasts
marketbeat.com - December 29 at 7:07 AM
realmoney.thestreet.com logoRayzeBio just downgraded at JPMorgan, here's why
realmoney.thestreet.com - December 28 at 10:26 PM
msn.com logoRBC says Bristol Myers/RayzeBio deal validates Fusion 's approach
msn.com - December 28 at 12:25 PM
realmoney.thestreet.com logoRayzeBio downgraded to Hold from Buy at Truist
realmoney.thestreet.com - December 28 at 1:27 AM
finance.yahoo.com logoBristol Myers' $4.1 Billion Deal For RayzeBio Sends RYZB Stock Soaring 100%
finance.yahoo.com - December 26 at 10:13 PM
msn.com logoWhy RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
msn.com - December 26 at 5:13 PM
finance.yahoo.com logoBristol Myers buying RayzeBio, FedEx buyback: Trending tickers
finance.yahoo.com - December 26 at 5:13 PM
za.investing.com logoMidday movers: Intel, RayzeBio, and more
za.investing.com - December 26 at 12:12 PM
benzinga.com logoHealth Care Company Bristol-Myers Squibb Announces Merger With RayzeBio
benzinga.com - December 26 at 12:12 PM
tmcnet.com logoRYZB Stock Alert: Halper Sadeh LLC Is Investigating RayzeBio, Inc.
tmcnet.com - December 26 at 12:12 PM
seekingalpha.com logoRayzeBio: New IPO With Good Data And Solid Premise
seekingalpha.com - December 26 at 12:12 PM
msn.com logoBristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion
msn.com - December 26 at 12:12 PM
finance.yahoo.com logoBristol Myers,RayzeBio deal, AstraZeneca buying Gracell
finance.yahoo.com - December 26 at 12:12 PM
investorplace.com logoWhy Is RayzeBio (RYZB) Stock Up 100% Today?
investorplace.com - December 26 at 11:01 AM
marketbeat.com logoRayzeBio's (RYZB) Market Perform Rating Reaffirmed at William Blair
marketbeat.com - December 26 at 10:58 AM
finance.yahoo.com logoBristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
finance.yahoo.com - December 26 at 7:12 AM
marketbeat.com logo
marketbeat.com - December 26 at 6:59 AM
seekingalpha.com logoTracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2023 Update
seekingalpha.com - December 12 at 11:34 PM
benzinga.com logoRayzeBio Stock (NASDAQ:RYZB) Dividends: History, Yield and Dates
benzinga.com - December 3 at 5:00 PM
markets.businessinsider.com logoTruist Financial Keeps Their Buy Rating on RayzeBio, Inc. (RYZB)
markets.businessinsider.com - November 30 at 8:16 PM
morningstar.com logoRayzeBio inc RYZB
morningstar.com - November 30 at 8:16 PM
finance.yahoo.com logoRayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 13 at 4:18 PM
finance.yahoo.com logoRayzeBio to Participate in Upcoming Investor Conferences in November 2023
finance.yahoo.com - November 6 at 7:05 PM
finance.yahoo.com logoRayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors
finance.yahoo.com - November 1 at 8:37 AM
finance.yahoo.com logoFDA selects RayzeBio to Participate in the Inaugural CDRP Program to Expedite Commercial Manufacturing Readiness for RYZ101 in GEP-NETs
finance.yahoo.com - October 24 at 12:54 PM
finance.yahoo.com logoRayzeBio to Present at European Society for Medical Oncology (ESMO) Congress
finance.yahoo.com - October 18 at 12:09 PM
markets.businessinsider.com logoRayzeBio’s Promising Future: A Buy Rating Based on Unique Radiopharmaceutical Approach and Strategic Growth
markets.businessinsider.com - October 11 at 7:47 AM
markets.businessinsider.com logoRayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan
markets.businessinsider.com - October 10 at 3:56 PM
seekingalpha.com logoRayzeBio: Initiating Coverage With Buy Rating And A Price Target Of $43
seekingalpha.com - October 10 at 2:10 PM
msn.com logoWilliam Blair starts RayzeBio at buy, cites in-house production capabilities
msn.com - October 6 at 7:57 PM
msn.com logoRayzeBio: Raising The Bar In Solid Tumor Radiotherapy
msn.com - September 27 at 8:16 AM
marketbeat.com logoRayzeBio (NASDAQ:RYZB) Trading 3.7% Higher on Insider Buying Activity
marketbeat.com - September 22 at 10:16 AM
finance.yahoo.com logoRayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - September 19 at 8:17 PM
msn.com logoRayzeBio, radiopharmaceuticals developer prices upsized $311 million IPO at $18.00 a share
msn.com - September 18 at 8:21 AM
money.usnews.com logoRayzeBio Inc.
money.usnews.com - September 18 at 8:21 AM
finance.yahoo.com logoRayzeBio, Inc. Announces Pricing of Upsized $311 Million Initial Public Offering
finance.yahoo.com - September 18 at 8:21 AM
seekingalpha.com logoIPO Update: RayzeBio Readies $245 Million IPO
seekingalpha.com - September 11 at 2:14 PM
seekingalpha.com logoLate Stage Biopharma RayzeBio Files For U.S. IPO
seekingalpha.com - August 25 at 4:44 PM
Get RayzeBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYZB and its competitors with MarketBeat's FREE daily newsletter.



RYZB Media Mentions By Week

RYZB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RYZB
News Sentiment
▼
1.83

0.92
▲
Average
Medical
News Sentiment

RYZB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RYZB Articles
This Week
▼
2

1
▲
RYZB Articles
Average Week

Get RayzeBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYZB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:RYZB) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -